Our Mission
Core Services
Drug Screening
Our drug screening services utilize endothelial cells to expedite the development of pharmaceuticals. By focusing on vascular health, we aim to provide faster and more efficient therapeutic solutions, significantly improving the drug development process.
Cell Therapy
Harnessing the power of biotechnology, our cell therapy services offer personalized vascular regeneration treatments. These therapies are designed to enhance patient care, providing innovative and effective solutions for those suffering from vascular conditions
NutrigeneAI App
In addition to our core services, NBL is committed to promoting personalized health and wellness through our NutrigeneAI app. This innovative application combines AI algorithms with personalized lifestyle and nutrition guidance, empowering individuals to make informed health decisions based on their unique profiles.
Market Opportunity
The market opportunity for NBL is vast, with significant growth potential in the biotechnology and personalized medicine sectors. We plan to target pharmaceutical companies, medical research institutions, and healthcare providers, offering advanced solutions that are both effective and cost-efficient.
Our Strategy
To ensure the successful launch and sustainability of our services, NBL has developed a detailed financial and operational strategy. Initial funding has been secured through angel investors, and further rounds of funding are planned to support ongoing research and development, marketing, and operational costs.
